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The AR86 strain of Sindbis virus causes lethal neurologic disease in adult mice. Previous studies have
identiﬁed a virulence determinant at nonstructural protein (nsP) 1 position 538 that regulates
neurovirulence, modulates clearance from the CNS, and interferes with the type I interferon pathway.
The studies herein demonstrate that in the absence of type I interferon signaling, the attenuated mutant
exhibited equivalent virulence to S300 virus. Furthermore, both S300 and nsP1 T538I viruses displayed
similar neurovirulence and replication kinetics in IPS-1/ mice. TRIF dependent signaling played a
modest role in protecting against disease by both S300 and nsP1 T538I, but did not contribute to control
of nsP1 T538I replication within the CNS, while MyD88 played no role in the disease process. These
results indicate that the control of the nsP1 T538I mutant virus is largely mediated by IPS-1-dependent
RLR signaling, with TRIF-dependent TLR signaling also contributing to protection from virus-induced
neurologic disease.
& 2012 Elsevier Inc. All rights reserved.Introduction
Sindbis virus (SINV) is the prototypic member of the alpha-
virus genus, and provides an excellent model of viral-induced
encephalomyelitis in mice. The SINV model has been used to
deﬁne the immune processes required for recovery and viral
clearance from neurons (reviewed in (Grifﬁn, 2010)). Survival of
mice infected with SINV is dependent on a number of factors,
including viral genetics, host age, and interactions with the host
innate and adaptive immune pathways (Dropulic et al., 1997,
Grifﬁn et al., 1994, Heise et al., 2000, Johnson et al., 1972, Kobiler
et al., 1999, Labrada et al., 2002, Park and Grifﬁn, 2009, Ryman
et al., 2000, Tucker et al., 1993, Tucker et al., 1997).
Among multiple SINV virus strains in the literature, wild-type
AR86 (hereafter S300) and neuro-adapted NSV are among the few
SINVs that maintain the ability to cause lethal neurologic disease
in adult mice (Simpson et al., 1996, Weinbren et al., 1956). AR86
and NSV were independently derived strains, and while immune-
pathology plays a major role during NSV infection, studies suggestll rights reserved.
t Chapel Hill, Department of
tt-Womack Bldg, CB #7292,
).that the immune system is protective during AR86 infection.
Previous studies with S300 identiﬁed four viral genetic determi-
nants of adult neurovirulence in outbred CD-1 mice, three of
which were in the nonstructural proteins (Suthar et al., 2005).
One of these determinants, a threonine (Thr) codon at nsP1
position 538, is essential for S300 neurovirulence, where an
attenuating isoleucine (Ile, consensus among non-neurovirulent
SINV viruses) at this position accelerates polyprotein processing
and expression from the 26S RNA promoter (Heise et al., 2003).
S300 expressing this Ile (referred to as nsP1 T538I hereafter), has
no defect in its ability to establish infection within the CNS
through 4 days post-infection (dpi), even exhibiting increased
early replication as compared to S300. However, in CD-1 mice,
nsP1 T538I viral RNA within the brain was dramatically reduced
at late times pi (Heise et al., 2000).
Type I interferon (interferon alpha/beta [IFN-a/b]) is critical
for host survival upon infection with alphaviruses (Ryman et al.,
2000, White et al., 2001). Indeed, SINV is highly sensitive to the
antiviral effects of IFN-a/b (Yin et al., 2009) and in vitro data
suggest that SINV antagonizes IFN-a/b induction via global shut-
off of host macromolecular synthesis (Burke et al., 2009, Frolova
et al., 2002). The nsP1 T538I virus shuts off host macromolecular
synthesis equivalently to S300, and therefore differences in host
shutoff do not explain the attenuation of the nsP1 T538I virus.
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II IFN-dependent signaling at or prior to the level of STAT
phosphorylation (Cruz et al., 2010, Simmons et al., 2010), sug-
gesting that this determinant affects neurovirulence via speciﬁc
interactions with the IFN pathway.
The type I IFN response to RNA viruses is initiated by the
ligation of ‘foreign’ pattern associated molecular patterns
(PAMPs) to speciﬁc Pattern Recognition Receptors (PRRs), which
include the Toll-like receptors (TLRs) and RIG-I-like receptors
(RLRs) (Janeway, 1989, Uematsu and Akira, 2006). The TLR family
is comprised of 12 known murine transmembrane receptors
(human TLR8 functions analogously to murine TLR7), including
four that are known to recognize RNA virus PAMPs (TLR2,–3,
4, and 7) (Akira, 2003, Brennan and Bowie, 2010, Colonna,
2007, Matsumoto et al., 2011, Uematsu and Akira, 2006, Yokota
et al., 2010). TLRs are type I transmembrane proteins that contain
extracellular leucine-rich repeats (LRRs), required to detect
PAMPs, and a cytoplasmic Toll/interleukin-1 receptor (TIR)
domain, required for activation of downstream signaling path-
ways. TLR3 and TLR7/8 are localized to intracellular vesicles,
where they recognize viral double-stranded (ds) RNA and
single-stranded RNA, respectively (Diebold et al., 2004, Lund
et al., 2004, Matsumoto et al., 2004). TLR2 and TLR4 are localized
to the cell surface, where they recognize viral structural proteins,
along with bacterial PAMPs (reviewed in (Kawai and Akira,
2007)). MyD88 is the essential adapter protein required for TLR
signaling through all of the TLRs, except for TLR3 and the MyD88-
independent pathway of TLR4 signaling, both of which can signal
via the adapter Toll/IL-1R domain-containing adapter inducing
IFN-b (TRIF, also known as Ticam-1) (Colonna, 2007, Kawai and
Akira, 2007, Kawai and Akira, 2011, Matsumoto et al., 2011,
Oshiumi et al., 2003, Sasai et al., 2010, Yamamoto et al., 2003).
The RLRs: melanoma differentiation-associated gene (Mda)5
and retinoic acid-inducible gene (RIG)-I, are localized to the
cytoplasm where they recognize speciﬁc RNA motifs within viral
RNA, such as 50 triphosphates on uncapped RNA and dsRNA
(Hornung et al., 2006, Kato et al., 2006, 2008, Loo et al., 2008,
Pichlmair et al., 2006). Once activated, the RLRs undergo a
conformational change that allows them to bind via a caspase
recruitment domain (CARD) to Interferon promoter stimulator
(IPS)-1 (also known as Cardif, Visa, and MAVS), which is located
on mitochondria-associated membranes (Horner et al., 2011,
Kumar et al., 2006).
The ligation of PRRs results in the activation of latent tran-
scription factors, interferon regulatory factor (IRF)-3, IRF-7, and
NF-kB, which in turn induce IFN, hundreds of interferon-
stimulated genes (ISGs), along with inﬂammatory cytokines
(reviewed in (Colonna, 2007, Hiscott, 2007)). To date, a number
of speciﬁc anti-SINV ISGs have been identiﬁed, including the
ubiquitin-like ISG15, Viperin, ISG12, ISG20, ZAP, dsRNA depen-
dent protein kinase (PKR) (Bick et al., 2003, Giannakopoulos et al.,
2009, Lenschow et al., 2005, 2007, MacDonald et al., 2007, Ryman
et al., 2005, Zhang et al., 2007). PKR is unique amongst these in
that it is also a PRR, recognizing short stem-loops within RNA in
an RLR-independent manner. Upon activation, PKR activates IRF-3
and induces the phosphorylation of eIF2a, which inhibits host and
certain viral translation and activates the host stress response
(Nallagatla et al., 2007).
Much emphasis has been placed on understanding which
host PRRs recognize alphavirus PAMPs and which PRRs mediate
IFN-a/b production. As such, Esen et al. demonstrated that neither
MyD88 nor TLR3 modulated mouse neurovirulence of SINV strain
NSV (Esen et al., 2012, Kim et al., 2008, Tabeta et al., 2006). In
primary murine ﬁbroblast cells, type I IFN induction by SINV was
shown to be largely dependent on PKR and Mda5 (Burke et al.,
2009), however Mda5 was not required for SINV-induced IFN-aproduction in primary bone-marrow derived macrophages (Gitlin
et al., 2006). Recently, IPS-1 was shown to be critical for activation
of IRF3 and IFN-a/b production within ﬁbroblasts after infection
with a related alphavirus, chikungunya virus (CHIKV) (White
et al., 2010). However, IPS-1 deﬁcient mice were only slightly
more susceptible to CHIKV peripheral infection, and exhibited
increased CHIKV replication in the serum at 48 h pi, but not in
other organs or at other time-points (Schilte et al., 2010). A study
with West Nile virus demonstrated that IPS-1 is essential for
the regulated activation of the innate and adaptive immune
responses (Suthar et al., 2010).
Given that the nsP1 T538I virulence determinant modulates
IFN-a/b induction, we set out to determine whether viral inter-
actions with speciﬁc IFN-a/b induction pathways were important
for regulating viral neurovirulence. To deﬁne the pathway(s) of
innate immune activation by nsP1 T538I, as well as the wild type
S300 virus, we directly compared S300 to nsP1 T538I i.c. infection
in mice on the C57BL/6J background deﬁcient for IFN-a/b receptor
(IFN-a/bR), MyD88, TRIF, and IPS-1 . The studies herein demon-
strate that in the complete absence of IFN-a/b signaling, the
attenuated virus regains virulence comparable to S300, and both
viruses show markedly increased virulence. This result suggests
that the AR86 strain of SINV interacts with the type I IFN system
to regulate virulence in vivo. We ﬁnd that the IPS-1 signaling
pathway plays a major role in controlling the attenuated nsP1
T538I virus and limiting SINV-induced morbidity and mortality.
Furthermore, we demonstrate that while the TLR pathways are
dispensable for nsP1 T538I replication control, TLR signaling via
the TRIF adapter molecule and not MyD88 may modulate the
neurovirulence of SINV.Results
A threonine at nsP1 position 538 Is A critical determinant of SINV
neurovirulence
The S300 strain of SINV is highly neurovirulent in adult mice,
(Heise et al., 2000, Simpson et al., 1996) and we have previously
identiﬁed four viral genetic determinants that regulate neuro-
virulence (Suthar et al., 2005). One of these determinants, a Thr
codon at nsP1 position 538, is essential for S300 neurovirulence,
where an attenuating Ile at this position decreases viral neuro-
virulence without adversely affecting viral replication in vitro or
the ability of the virus to establish infection within the CNS (Heise
et al., 2000). Previous studies with this attenuated mutant were
conducted in outbred CD-1 mice. However, to further analyze
how this virus interacts with the host immune response, we
conﬁrmed that the nsP1 T538I mutant exhibits an attenuated
phenotype after infection of inbred C57BL/6J mice. As shown in
Fig. 1A, infection of female adult C57BL/6J mice with S300
resulted in 100% lethality with a mean survival time (MST) of
6.3 days (n¼49) post i.c. inoculation. Infection with nsP1 T538I
resulted in 62.5% mortality and an increased MST of 10.7 dpi
(n¼56) (Fig. 1A and Tables 1 and 2). Moreover, S300 infected
C57BL/6J mice displayed enhanced weight loss from 4–7 dpi as
compared to nsP1 T538I infected mice. C57BL/6J mice infected
with nsP1 T538I began to regain weight beginning on day 9 pi,
while S300 infected mice never showed signs of weight gain/
recovery (Fig. 1B, Table 3). Therefore, although the attenuated
mutant caused more severe disease in the C57BL/6J background
than was previously reported in outbred CD-1 mice, the mutant
virus is still signiﬁcantly attenuated in C57BL/6J mice when
compared to S300 virus (Fig. 1). Further analysis indicated
that the nsP1 T538I virus replicated equivalently to S300 virus
at 1 and 3 dpi within the CNS, however nsP1 T538I titers were
Table 1
Statistical differences in survival curves within each knockout mouse strain after
i.c.infection with S300 or nsP1 T538I viruses.
Virus Mouse strain Compared to:
Virus Mouse strain Survival curve
signiﬁcance
S300 C57BL/6J S300 IFN-a/bR/ po0.0001(****)
S300 C57BL/6J S300 IPS-1/ po0.001(***)
S300 C57BL/6J S300 MyD88/ n.s.
S300 C57BL/6J S300 TRIF/ po0.05(*)
nsP1 T538I C57BL/6J nsP1 T538I IFN-a/bR/ po0.0001(****)
nsP1 T538I C57BL/6J nsP1 T538I IPS-1/ po0.0001(****)
nsP1 T538I C57BL/6J nsP1 T538I MyD88/ n.s.
nsP1 T538I C57BL/6J nsP1 T538I TRIF/ n.s.
S300 C57BL/6J nsP1 T538I C57BL/6J po0.0001(****)
S300 IFN-a/bR / nsP1 T538I IFN-a/bR/ n.s.
S300 IPS-1/ nsP1 T538I IPS-1/ n.s.
S300 MyD88 / nsP1 T538I MyD88/ po0.001(***)
S300 TRIF/ nsP1 T538I TRIF/ po0.0001(****)
Table 2
Percent mortality and mean survival times after i.c. infection with S300 or nsP1
T538I within each mouse strain.
Mouse strain Virus % Mortality Mean survival
time (days)
C57BL/6Ja S300 100 6.3
C57BL/6Ja nsP1 T538I 62.5 10.7
IFN-a/bR / S300 100 3.5
IFN-a/bR / nsP1 T538I 100 3.4
IPS-1/ S300 100 5.1
IPS-1/ nsP1 T538I 100 5.4
MyD88 / S300 100 6.2
MyD88 / nsP1 T538I 75 9.3
TRIF/ S300 100 5.3
TRIF/ nsP1 T538I 84.2 8.6
a Values are pooled across all experiments.
Fig. 1. The mutant virus nsP1 T538I is attenuated in C57BL/6J mice as compared to S300 wild-type virus. Adult 9–12-week-old female C57BL/6J mice were infected i.c.
with 103 PFU of S300 or nsP1 T538I virus and monitored daily for (A) survival, (B) weight loss, and (C) brain and (D) spinal cords were harvested at 1, 3, 5, and 6 days post
infection for viral titer by plaque assay. Survival data are presented as the pooled results of at least 3 experiments. Weight loss data are presented as the meansþthe
standard deviation of 16 experiments. Viral titer data are shown as the mean of a single experiment and are representative of at least three experiments. The number of
mice infected per virus is indicated in parentheses. Asterisks denote po0.01(**), po0.001(***), or po0.0001(****). The horizontal dashed line indicates the lower limit of
assay sensitivity.
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6 dpi, and in the spinal cord on day 6 pi (Fig. 1C and D). These
results suggest that the nsP1 538 virus is able to efﬁciently
establish infection within the CNS, but that the virus is likely
cleared more efﬁciently than S300.
The nsP1 T538I displays comparable virulence to S300 in the absence
of a functional type I IFN system
We have previously demonstrated that nsP1 T538I induces
higher amounts of IFN-a/b compared to S300 in the serum ofinfected CD-1 and C57BL/6J mice and in cell culture (Cruz et al.,
2010). Therefore, to evaluate whether the mutant virus would
regain wild-type virulence in the absence of IFN-a/b signaling we
infected IFN-a/bR deﬁcient mice with either S300 or nsP1 T538I
and assessed neurovirulence. Consistent with previous studies
(Ryman et al., 2000), IFN-a/bR/ mice were highly susceptible
to infection with SINV, and exhibited rapid and equivalent
mortality and weight loss upon infection with either S300
or nsP1 T538I viruses (Fig. 2A and B). Speciﬁcally, infection of
IFN-a/bR/ mice with either S300 or nsP1 T538I resulted in
100% mortality and an MST of 3.5 and 3.4 dpi for S300 and nsP1
T538I, respectively. (Fig. 2A, Tables 1 and 2). Furthermore, both
S300 and nsP1 T538I replicated approximately 3 logs higher
Table 3
Statistical differences in weight loss on day of peak disease within each knockout mouse strain after i.c.infection with S300 or nsP1
T538I viruses.
Virus Mouse strain Compared to:
Virus Mouse strain Weight loss
signiﬁcance
Statistic
performed on
S300 C57BL/6J S300 IFN-a/bR/ po0.0001(****) day 3
S300 C57BL/6J S300 IPS-1/ n.s. day 5
S300 C57BL/6J S300 MyD88/ n.s. day 5
S300 C57BL/6J S300 TRIF/ n.s. day 5
nsP1 T538I C57BL/6J nsP1 T538I IFN-a/bR/ po0.0001(****) day 3
nsP1 T538I C57BL/6J nsP1 T538I IPS-1/ n.s. day 5
nsP1 T538I C57BL/6J nsP1 T538I MyD88/ n.s. day 5
nsP1 T538I C57BL/6J nsP1 T538I TRIF/ po0.01(**) day 5
S300 C57BL/6J nsP1 T538I C57BL/6J po0.001(***) day 5
S300 IFN-a/bR/ nsP1 T538I IFN-a/bR/ n.s. day 3
S300 IPS-1/ nsP1 T538I IPS-1/ po0.0001(****) day 5
S300 MyD88/ nsP1 T538I MyD88/ po0.0001(***) day 5
S300 TRIF/ nsP1 T538I TRIF/ n.s. day 5
Fig. 2. Both S300 and nsP1 T538I show equivalent and enhanced virulence in the absence of the IFN-a/b response. Adult 9–12-week-old female C57BL/6J and IFN-a/bR
deﬁcient mice were infected i.c. with 103 PFU of S300 or nsP1 T538I virus. Equivalent and rapid (A) lethality and (B) weight loss with both S300 and nsP1 T538I infection of
IFN-a/bR / mice. The number of mice infected per virus is indicated in parentheses, and data are compiled from a minimum of two experiments. Infectious virus data are
shown as the mean of 2 pooled experiments, and was assayed at day 3 pi within the (C) brain and (D) spinal cord of C57BL/6J and IFN-a/bR/ mice. Asterisks denote
po0.0001(****). The dashed line indicates the lower limit of assay sensitivity.
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pared to C57BL/6J mice on day 3 pi (Fig. 2C and D). These data
demonstrate that the mutant virus displays virulence comparable
to S300 in the absence of type I IFN signaling. When combined
with our previous in vitro and in vivo studies (Cruz et al., 2010),
this observation suggests that interactions with the type I IFN
system contribute to the attenuation of the nsP1 T538I mutant
in vivo, and contribute to overall protection from S300 and nsP1
T538I-induced disease.
MyD88-dependent TLR signaling Is dispensable for protection and
control of nsP1 T538I
Given that the nsP1 T538I mutant exhibited similar levels of
virulence as S300 in IFN-a/bR/ mice, we sought to determinewhich type I IFN induction pathway(s) was responsible for
regulating the attenuation of the nsP1 T538I mutant. Therefore,
we assessed the role of the TLR and RLR-mediated type I IFN
induction pathways in the virulence of S300 and nsP1 T538I.
To begin to assess the role of the TLRs in mediating type I IFN
induction, we took advantage of the fact that there are a limited
number of adapter molecules that regulate signaling by TLRs:
Myd88 and TRIF (Akira, 2003). To ﬁrst assess the role of the
MyD88-dependent TLRs, we infected C57BL/6J and MyD88/
mice i.c. with 103 PFU of S300 or nsP1 T538I. As shown in Fig. 3A
and B, the attenuation of nsP1 T538I as compared to S300 in
MyD88/ mice was comparable to C57BL/6J mice, as measured
by survival, MST, and weight loss, indicating that the MyD88-
dependent TLRs do not contribute to the attenuation of the nsP1
T538I virus in vivo (Tables 1–3). Furthermore, MyD88 signaling
Fig. 3. TLR signaling through MyD88 is not required for protection or control of nsP1 T538I infection. Adult 9–12-week-old female C57BL/6J and MyD88/ mice were
infected i.c. with 103 PFU of S300 or nsP1 T538I virus. Differential (A) survival and (B) weight loss between S300 and nsP1 T538I infected MyD88/ mice. The number of
mice infected per group is indicated in parentheses. Infectious virus was assayed at 5 days pi in the (C) brain and (D) spinal cord. Asterisks denote po0.01(**) or
po0.001(***). Titer data are representative of two or more experiments. The dashed line indicates the lower limit of assay sensitivity.
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virus in the brain (Fig. 3C) or spinal cord (Fig. 3D) at day 5 pi, the
time-point at which control of nsP1 T538I is ﬁrst observed in
C57BL/6J mice. In addition, the attenuated nsP1 T538I virus
phenotype was maintained in TLR7/ mice (unpublished
results), thus conﬁrming the MyD88 result, and ruling out a
speciﬁc role for TLR7. Taken together, these data indicate that
MyD88-dependent TLR signaling does not contribute to the
attenuation of the nsP1 T538I virus.
TRIF-dependent TLR signaling Is not required for nsP1 T538I
replication control, but does contribute to protection from virus-
induced disease during SINV infection
In order to evaluate the role of TRIF-dependent signaling in the
pathogenesis of S300 or the nsP1 T538I mutant, we infected
C57BL/6J or TRIF/ mice with S300 or nsP1 T538I and measured
survival and weight loss, as well as virus-induced pathology and
viral burden within the brain and spinal cord. In contrast to our
ﬁndings with MyD88, TRIF/ mice exhibited a moderate
increase in susceptibility to both S300 and nsP1 T538I viruses
compared to C57BL/6J mice (Fig. 4A, B, G). TRIF/ mice infected
with S300 succumbed to disease with a slightly more rapid MST
of 5.3 dpi, as compared to 6.7 dpi for S300 infected C57BL/6J mice,
while MSTs for the nsP1 T538I virus were reduced from 9.9 days
in C57BL/6J mice to 8.6 days in TRIF/ mice (Tables 1, 2). There
was a trend towards increased mortality for TRIF/ mice
compared to C57BL/6J, and this difference was statistically sig-
niﬁcant for the S300 virus (Fig. 4A and Table 1). For the nsP1
T538I virus, the differences in survival between wild type and
TRIF/ mice did not reach statistical signiﬁcance (Table 1),
however the pattern of increased mortality in TRIF/ mice was
repeatable in 3 independent experiments, suggesting that TRIF
may also play a role in protecting from nsP1 T538I-induced
mortality. Analysis of weight loss following infection found thatTRIF/ mice infected with nsP1 T538I showed signiﬁcantly
enhanced weight loss as compared to C57BL/6J mice on 3–6 dpi
(Fig. 4B, Table 3). These results further suggest that TRIF does
contribute to protection against virus-induced disease following
both S300 and nsP1 T538I infection, though this effect was
relatively modest. Furthermore, since the nsP1 T538I mutant
did not show full restoration of virulence in TRIF/ mice, these
results suggest that other IFN induction pathways also contribute
to the attenuated phenotype of the nsP1 T538I mutant.
To further assess the role of TRIF in the pathogenesis of the
nsP1 T538I virus, we evaluated viral loads within the CNS at day
5 pi. Importantly, TRIF/ animals showed similar levels of viral
replication compared to C57BL/6J animals when infected with
either S300 or nsP1 T538I. By 5 dpi, nsP1 T538I viral titers in the
brains of TRIF/ mice were signiﬁcantly lower compared to S300
titers (Fig. 4C), and were reduced (although not statistically
signiﬁcant) in spinal cords (Fig. 4D). These results, which suggest
that TRIF is not involved in the control of nsp1 T538I replication,
were further supported by in situ hybridization for viral RNA
within the CNS, where TRIF/ mice were indistinguishable from
C57BL/6J mice in terms of the distribution and intensity of viral
RNA signal within the hippocampus (Fig. 4E) or brain stem
(Fig. 4F) following infection with either S300 or the nsP1
T538I virus.
Given that TRIF contributes to protection from virus-induced
disease, but does not affect either viral loads or viral distribution
within the CNS, we assessed whether TRIF deﬁciency might lead
to enhanced pathology within the CNS of mice infected with
either the S300 or nsP1 T538I viruses. As shown in Fig. 4G, S300
infection resulted in neuronal dropout within the hippocampus of
C57BL/6J mice, and this was unchanged in TRIF/ animals.
Notably, although the nsP1 T538I virus caused reduced damage
within the hippocampus of C57BL/6J mice, we report enhanced
neuronal dropout in TRIF/ mice. While the destruction of
hippocampal neurons on their own is not likely to contribute to
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Fig. 4. TRIF signaling is not required for viral replication control of nsP1 T538I, but TRIF may play a minor role in protection from SINV-induced disease. Adult 9–12-week-
old female C57BL/6J and TRIF/ mice were infected i.c. with 103 PFU of S300 or nsP1 T538I virus. (A) Survival and (B) weight loss of S300 and nsP1 T538I infected C57BL/
6J or TRIF/ mice are shown. The number of mice infected per group is indicated in parentheses. Infectious virus was assayed at 5 days pi within the (C) brain and
(D) spinal cord. Titer data are representative of two or more experiments. Asterisks denote po0.05(*) or po0.01(**). The dashed line indicates the lower limit of assay
sensitivity. Mice were perfused with 15 mL of 4% PFA for in situ hybridization and H&E, and brains were parafﬁn embedded and cut sagitally. Sections were subjected to
in situ hybridization with a riboprobe speciﬁc for SINV AR86 and shown are (E) hippocampus and (F) spinal cord regions. Nonspeciﬁc binding controls included sections
from mock-infected mice probed with the AR86 riboprobe, and sections from infected mice probed with a riboprobe speciﬁc for Epstein-Barr virus (not shown). (G) H&E
stained brain sections depicting the hippocampus.
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results suggest the TRIF-dependent signaling does play a neuro-
protective role independently of viral replication during infection
with the nsP1 T538I virus.
IPS-1 Is required for control of CNS replication and protection upon
nsP1 T538I infection
Since TRIF-dependent signaling could not fully explain the
attenuated phenotype of the nsP1 T538I virus, we next evaluated
whether the cytoplasmic RLR pathway, which is dependent upon
the adapter molecule IPS-1, was required to control the nsP1T538I virus within the CNS. In contrast to the MyD88/ and
TRIF/ mice, the nsP1 T538I virus exhibited nearly complete
restoration of virulence in the IPS-1 / animals, with both the
wild-type S300 and nsP1 T538I viruses having nearly identical
survival curves (Fig. 5A, Tables 1, 2). Survival curve analysis
indicates two important points: (1) the survival curve of S300 is
not signiﬁcantly different from that of nsP1 T538I in IPS-1 /
mice, and (2) both viruses cause more rapid death in IPS-1 /
mice compared to C57BL/6J mice. The MST of C57BL/J mice
infected with S300 or nsP1 T538I were 6.1 and 10.3 dpi, respec-
tively. However, IPS-1 / mice show similar MSTs when infected
with S300 or nsP1 T538I (5.1 and 5.4 dpi, respectively), suggesting
Fig. 5. IPS-1 is required for protection from nsP1 T538I and contributes to control of nsP1 T538I. Adult 9–12-week-old female C57BL/6J and IPS-1/ mice were infected
i.c. with 103 PFU of S300 or nsP1 T538I virus. Similar (A) survival and (B) weight loss curves between S300 and nsP1 T538I infected IPS-1/ mice. The number of mice
infected per group is indicated in parentheses. Infectious virus was assayed at 1, 3, and 5 days pi in the (C) brain and (D) spinal cord. Titer data are representative of two or
more experiments. Asterisks denote po0.05(*), po0.01(**), po0.01(***), and po0.0001(****). The dashed line indicates the lower limit of assay sensitivity.
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nsP1 T538I and likely S300 virus infection (Tables 1, 2). We next
assessed the role of IPS-1 in modulating weight loss of S300 and
nsP1 T538I infected mice by statistically evaluating infected IPS-1
/ and C57BL/6J mice from days 0–5 pi (Fig. 5B, Table 3). While
there were no differences in weight loss from 0–3 dpi, on day 4 pi
S300 and nsP1 T538I infected IPS-1 / mice exhibited signiﬁ-
cantly different percentages of weight loss. This was also true for
day 5 pi, though with the caveat being that day 5 pi data is
censored due to death.
To determine the role of IPS-1 in regulating viral replication in
the CNS, viral burden was assayed in the brain and spinal cords on
1, 3, and 5 dpi. There were no differences between host genotypes
or virus genotypes at 1 dpi. At 3 dpi, both viruses replicated
to signiﬁcantly higher levels in the brains and spinal cords of
IPS-1 / mice as compared to C57BL/6J animals (Fig. 5C and D).
On day 5 pi, the nsP1 T538I virus replicated to signiﬁcantly higher
levels within the brain and spinal cords of IPS-1 / mice
compared to C57BL/6J animals, suggesting that IPS-dependent
signaling is at least partially responsible for the faster clearance of
the nsP1 T538I mutant. However, nsP1 T538I titers were not fully
restored to the levels of S300 in IPS-1 / mice, indicating that
other IFN signaling pathways also contribute to nsP1 T538I viral
control. These results were conﬁrmed by virus-speciﬁc real-time
PCR, where levels of nsP1 T538I viral genomic and 26S RNA
within the brains and spinal cords were signiﬁcantly increased in
IPS-1 / mice compared to C57BL/6J mice (Fig. 6A and B).
Furthermore, the nsP1 T538I virus exhibited stronger intensity
and more broadly distributed viral signal within the CNS of
IPS-1 / mice compared to C57BL/6J animals, further suggestingthat IPS-1 plays a major role in limiting nsP1 T538I replication at
late times pi. However, the fact that the mutant virus did not
achieve the same level of replication as S300 in IPS-1 / animals
suggests that other IFN induction pathways may act in concert
with IPS-1 to control the nsP1 T538I mutant.
To further assess the impact of IPS-1 deﬁciency on protection
from nsP1 T538I-induced disease, we compared damage and
inﬂammation in C57BL/6J mice and IPS-1 / mice following
S300 or nsP1 T538I infection. In C57BL/6J mice, S300 caused more
severe neuronal damage within the hippocampus at 5 dpi than
the nsP1 T538I virus. However, in IPS-1 / mice, both viruses
caused severe damage to neurons in the hippocampus (Fig. 6E)
and cortex (unpublished results), with pyknotic neurons and
signiﬁcant neuronal dropout with both viruses (Fig. 6E).Discussion
The type I IFN system plays an essential role in the control and
tropism of numerous viruses, including alphaviruses (Couderc
et al., 2008, Fragkoudis et al., 2007, Ryman et al., 2000, 2007,
Ryman and Klimstra, 2008, White et al., 2001). As a result,
alphaviruses have evolved mechanisms to avoid or actively
suppress the type I IFN system. Therefore, dynamic interplay
between virus and host likely has major impacts on the outcome
of disease. Previous work from a number of groups has demon-
strated that alphaviruses, including SINV, avoid IFN-a/b induction
at least in part through their ability to nonspeciﬁcally shutoff host
RNA and protein synthesis (Aguilar et al., 2007, Frolov, 2004,
Frolova et al., 2002, Toribio and Ventoso, 2010). Recent studies
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Fig. 6. Increased quantity and distribution of viral RNA and neuronal damage in IPS-1 / mice infected with S300 and nsP1 T538I as compared with C57BL/6 mice infected
with nsP1 T538I. C57BL/6J and age-matched IPS-1 / mice were infected i.c. with 103 PFU of S300 or nsP1 T538I virus. Brains were harvested at 5 days pi. (A, B) Mice were
perfused with 15 mL of PBS, and RNA was harvested prior to qRT-PCR using primer/probe sets speciﬁc for SINV (A) 49S genomic RNA or (B) 26S subgenomic RNA. Asterisks
denote po0.05(*), po0.01(**), po0.001(***), or po0.0001(****). Mice were perfused with 15 mL of 4% PFA for in situ hybridization and H&E, and brains were parafﬁn
embedded and cut sagitally. Sections were subjected to (C, D) in situ hybridization with a riboprobe speciﬁc for SINV AR86 or (E) H&E. Nonspeciﬁc binding controls
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shown). Data shown are representative of three experiments with at least three mice per group.
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CHIKV, Venezuelan equine encephalitis virus, and SINV, indicate
that these viruses are also able to modulate IFN-a/b induction and
signaling independently of host cell shutoff (Breakwell et al.,
2007, Cruz et al., 2010, Fros et al., 2010, Simmons et al., 2009,
2010). In the context of SINV infection, our research group has
demonstrated that a determinant at nsP1 position 538 of the
neurovirulent AR86 strain of SINV modulates both IFN-a/b
induction (Cruz et al., 2010) and IFN-a/b signaling in a Jak/
STAT-dependent manner but a host shutoff independent manner
(Simmons et al., 2010). Speciﬁcally, nsP1 T538I induces greater
amounts of type I IFN than S300 in both cell culture and in the
serum of infected mice (Cruz et al., 2010). This determinant at
nsP1 538 also plays a major role in neurovirulence, where
the presence of the nsP1 538 Ile is also severely attenuating
for S300 neurovirulence (Heise et al., 2000, 2003, Suthar et al.,
2005). Therefore, we set out to determine whether the type I IFN
system was required for the attenuated phenotype of the nsP1
T538I mutant in vivo, and if so, which host sensing pathway
or pathways contributed to this phenotype. These studies
clearly demonstrate that in the absence of a functional type I
IFN system, the attenuated mutant is as virulent as wild-type
S300, and that both viruses cause more severe disease. In addi-
tion, the IPS-1-dependent host sensing pathway, and to a lesserextent, the TRIF-dependent signaling pathways contribute to this
phenotype.
To our knowledge, this is the ﬁrst time that IPS-1-dependent
signaling has been linked to the control of a neurovirulent
alphavirus. Despite the critical role of IPS-1, it does not explain
all of the protection and replication control provided by type-I
interferon, because IFN-a/bR/ mice succumbed to infection
approximately 2 days before IPS-1 / mice, and IFN-a/bR/
supported approximately 1.5 logs greater replication in the CNS,
than did IPS-1 / mice at 3 dpi. Our results are consistent with
those of several other groups that have demonstrated that the
cytoplasmic RNA sensing pathways play a major role in the
response to alphaviruses. IPS-1-dependent signaling pathways
have been shown to play a major role in IFN-a/b induction by
SINV (Burke et al., 2009) and CHIKV (White et al., 2010, Schilte
et al., 2010). In vivo studies demonstrated that IPS-1 / mice
support increased CHIKV replication in the serum at 48 hpi, but
not in other organs or at other time-points tested (Schilte et al.,
2010). While no IPS-1 / mice died from infection with CHIKV,
100% of IFN-a/bR/ mice infected with CHIKV died within 4 dpi
(Schilte et al., 2010).
A recent study investigated the role of TLRs during infection
with an independently derived neurovirulent strain of SINV,
neuro-adapted SINV (NSV). Speciﬁcally, Esen et al. infected mice
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Unc93b13d/3d, that are incapable of signaling through TLR3,
TLR7, and TLR9. These mice fail to transfer TLRs from the ER to
the endosome (Esen et al., 2012, Kim et al., 2008, Tabeta et al.,
2006). While Unc93b13d/3d mice were more susceptible to SINV
strain NSV infection, neither MyD88/ nor TLR3/ mice were
more susceptible, suggesting that TLRs do not regulate the
pathogenesis to NSV infection (Esen et al., 2012). Consistent with
these results, we did not ﬁnd a role for MyD88 in protecting mice
during infection with either the wild type S300 or the mutant
nsP1 T538I virus. However, in contrast to the results with NSV, we
did ﬁnd that TRIF dependent signaling plays a modest role in
protecting from virus-induced disease and neuronal damage
following infection with both the wild type and mutant AR86
viruses. Though it remains to be determined why TRIF dependent
signaling plays a different role during AR86 and NSV infection,
these results do indicate that these two neurovirulent virus
strains do differ somewhat in their interactions with the host
Based on the critical protective role for IPS-1 in nsP1 T538I
pathogenesis, we are currently assessing the roles of RIG-I and
Mda5 in sensing the nsP1 T538I mutant. We have previously
shown that the nsP1 T538I mutation leads to enhanced 26S RNA
synthesis. Since RIG-I and Mda5 recognize viral RNA, the nsP1
T538I virus may be producing more ligand in virally infected cells
compared to wild-type S300 (Heise et al., 2003). Studies are
currently underway to evaluate whether enhanced 26S RNA
expression or some other aspect of the nsP1 T538I mutant virus
life cycle leads to enhanced type I IFN induction via IPS-1, TRIF, or
interactions between the two pathways compared to wild-type
S300. Furthermore, we have demonstrated that TLR4 is not
required for protection from nsP1 T538I disease (unpublished
results), suggesting that TLR3-dependent signaling may be respon-
sible for the protective role of TRIF, and therefore TLR3/ mice
are currently being tested.
Another possible explanation for why IPS-1 / mice are not
as susceptible to SINV as IFNa/bR/ mice is that IFN signaling is
critical for protection. Even a small amount of type I IFN can be
ampliﬁed through IFN signaling on infected and uninfected cells.
IFN signaling is functional in IPS-1 / mice, and we have found
that type I IFN is still produced in IPS-1 / mice (unpublished
results). Although IFNa/bR/ produce type I IFN, they are
incapable of responding, possibly explaining the extreme
susceptibility.
Type I IFNs exert antiviral effects through the upregulation of
ISGs, which possess antiviral activity, and by stimulating the
adaptive immune response (Coro et al., 2006, Fink et al., 2006,
Havenar-Daughton et al., 2006, Purtha et al., 2008). Several ISGs,
such as Viperin, ZAP, ISG15, ISG12, ISG20, and PKR have been
shown to contribute to control of alphavirus (Bick et al., 2003,
Giannakopoulos et al., 2009, Labrada et al., 2002, Lenschow et al.,
2005, 2007, MacDonald et al., 2007, Ryman et al., 2005, Zhang
et al., 2007), and future studies will address whether IPS-1-
dependent expression of these or other ISGs have antiviral
activity against the nsP1 T538I virus.
Adaptive immune pathways, namely antibody, IFN-g, and T
cells, also play key roles in SINV control and clearance (Binder and
Grifﬁn, 2001, Burdeinick-Kerr and Grifﬁn, 2005, Burdeinick-Kerr
et al., 2009, Byrnes et al., 2000, Grifﬁn et al., 1997, Grifﬁn, 2010).
IPS-1 has previously been shown to modulate the adaptive
immune response during West Nile virus infection (Suthar et al.,
2010), and thus it will also be important to determine if RLR
signaling contributes to virus-speciﬁc T cell or antibody responses
via IPS-1 . We have seen no difference in the quantity of serum
anti-SINV antibodies or neutralizing antibody production
between S300 and nsP1 T538I infected C57BL/6J at 6 dpi (unpub-
lished results). Evidence has shown that IPS-1 and TRIFcooperatively contribute to the adjuvant effects of poly:IC, a
result that was only determined by examining the IPS-1 and TRIF
double-knockout mouse (Kumar et al., 2008). While we have
shown the independent roles of the TLR and RLR pathways,
studies are underway to test how these pathways might coopera-
tively interact.Conclusions
In summary, we have demonstrated that the type I IFN pathway
via IPS-1, but not TLR-dependent signaling pathways are essential
for controlling nsP1 T538I replication. Furthermore, IPS-1, and to a
lesser extent TRIF-dependent signaling protected mice from nsP1
T538I and S300 induced disease. These studies suggest that the
in vivo attenuation of the nsP1 T538I virus is predominantly
regulated by the IPS-1- dependent sensing pathway.Materials and Methods
Mice
Female C57BL/6J, TRIF/Ticam-1 deﬁcient (stock 005037), and
MyD88 deﬁcient (stock 009088) mice were obtained commer-
cially from Jackson Labs. IFN-a/bR/ mice on the C57BL/6J
background were provided by Jason Whitmire (UNC-Chapel Hill),
and were originally made by Jonathan Sprent (The Scripps
Research Institute) (Kolumam et al., 2005). IPS-1 / (STI) mice
were generated in the Gale laboratory as previously described
(65). Mice were genotyped and bred in-house under speciﬁc-
pathogen-free conditions. Adult 9–12 -week-old female mice
were anesthetized with a ketamine-xylazine mixture prior to
intracranial (i.c.) inoculation with 103 PFU of virus in diluent
(Dulbecco’s Phosphate Buffered Saline [1X DPBS; GIBCO] supple-
mented with 1% donor calf serum (DCS), 0.122 mg/mL CaCl2, and
0.10 mg/mL MgCl); total volume, (10 ml). Mock-infected mice
received diluents alone. Mice were weighed daily and monitored
for disease signs. As required by the UNC-CH Institutional Animal
Care and Use Committee (IACUC), infected mice were euthanized
during the experiment either when mice dropped below 70% of
initial body weight or when mice exhibited severe disease signs.
Mouse experiments were approved and performed in accordance
with all IACUC guidelines.
Viral burden analysis
For in vivo growth studies, mice were inoculated as above and
sacriﬁced by exsanguination followed by perfusion with 15 ml of
PBS. Indicated tissues were removed, weighed, homogenized
using glass-beads in a tissue homogenizer and stored at 80 1C
until viral load was assessed by a standard plaque assay on baby
hamster kidney (BHK-21) cells as previously described (Heise
et al., 2000).
Virus production
The wild-type AR86 infectious clone is denoted as S300, and
the mutant virus with a single amino acid change (nsP1 T538I) is
denoted as S340. Both pS300 and pS55 plasmids, which differ
only in the linearization site used, each encode wild-type AR86;
thus, S300 and the previously designated S55 (Heise et al., 2000,
2003) are synonymous. Similarly, S51 is synonymous with S340/
nsP1 T538I (Heise et al., 2000, Suthar et al., 2005). Virus stocks
were made as described previously (Heise et al., 2000). Brieﬂy,
viral cDNA plasmids were linearized with PmeI and used as
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speciﬁc mMessage Machine in vitro transcription kits (Ambion).
Capped, poly-adenylated transcripts were then electroporated
into BHK-21 cells, and after 24 h, supernatants were harvested,
and clariﬁed at 3,000 RPM for 15 min. All virus stocks were
titrated by plaque assay on BHK-21 cells.
In situ hybridization
Hybridizations were performed with a 35S UTP-labeled AR86-
specifec riboprobe derived from pDS-45 . Clone pDS-45 was
constructed, linearized, and transcribed as described previously
(Heise et al., 2000). This riboprobe encodes the last 187 nucleo-
tides of the nsP4 gene, the 26S promoter region, and the ﬁrst 209
nucleotides of the capsid gene. A riboprobe speciﬁc for Epstein-
Barr virus was used as a control probe for nonspeciﬁc binding. The
AR86 probe was hybridized to tissues from PBS-inoculated mice
as an additional control for nonspeciﬁc binding. The in situ
hybridizations were performed according to the method of
Charles et al., (Charles et al., 1995) by using 25 mL of probe/slide
at 5104 cpm/mL.
Histological analysis
Mock-infected or SINV-infected mice were sacriﬁced by exsan-
guination followed by perfusion with 15 ml of PBS, 4% parafor-
maldehyde (PFA), pH 7.3. Brains were embedded in parafﬁn and
10 mm sections were prepared and stained with hematoxylin and
eosin (H&E) by the UNC histopathology core facility. Sections
were analyzed using an Olympus BX61 microscope ﬁtted with a
QImaging RETIGA 4000R color camera for digital imaging.
Real-time PCR
For SINV genome analysis, a TaqMan primer-probe set
(designed with the Primer Express software) speciﬁc for the
nsP3 and the E2 region of SINV were used. The primer and probe
sequences for the TaqMan primer-probe set were as follows:
nsP3: forward primer, 50- ATATCGCCTCGTTCGACAAAA-30; reverse
primer, 50- ACACCCAGGTCTTCCAAGATCA-30; and probe, 50- TAT-
GGCGTTAACCGGCCT-30, E2: forward primer, 50- CGCGGCCT-
GGTGTACAAC-30; reverse primer, 50- CCAAACGCTCCTGGTTTCA-
30; and probe, 50- TGACTTTCCGGAATACGGA-30. Brain RNA was
isolated with an RNeasy Lipid Tissue Mini kit (Qiagen). cDNAs
were synthesized from mRNA by reverse transcription with the
respective tagged primer. RT-PCR (qRT-PCR) was then performed
with Prism 7000 real-time PCR system. cDNA standard curves for
the SINV genome and 26S RNA were generated to ensure optimal
primer-probe efﬁciency and to assign relative genome and
26S RNA copy numbers to directly compare each sample.
Statistical analysis
Differences in Kaplan-Meier survival curves were analyzed
by Mantel-Haenszel test. Weight loss curves across days were
initially analyzed by MANOVA. If overall differences were
observed across weight loss curves, ANOVA and Tukey’s Honestly
Signiﬁcant Difference test were used to determine factors
inﬂuencing weight-loss within a given day. Survival curves and
weight loss data were analyzed using the R statistical language
(R Development Core Team, 2010), with the survival package
for survival analysis. For in vivo viral burden analysis, a two-way
ANOVA, with Bonferonni correction was used to determine
statistical differences. Viral burden data were analyzed using
Prism software (GraphPad Prism5, San Diego, CA).Acknowledgments
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